Mitral Valve Repair With the Chord-X System: A Long Term Evaluation
← catalyst calendarNCT07413926 · readout ≤ 2,781 d
Sponsored by Artivion Inc. (industry) · AORT — their whole pipeline →.
Phase
—
Status
Not yet recruiting
Study type
Observational
Enrollment
110estimated
Sites
4
Countries
Italy, United Kingdom, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jun 2026 | estimated | When the study began enrolling |
| Primary completion | Mar 2034 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2034 | estimated | The whole study's end, after follow-up |
| First posted | 2026-02-17 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Mitral Regurgitation (MR)
Intervention
- Device: Chord-X system implant
Primary outcome
what the primary-completion date above is the date OFRecurrent Mitral Regurgitation
measured The primary endpoint will be evaluated at all time points in the study, through 10 years post-implant.
Publications
- PMID 35690138 — cited as background
- PMID 26170468 — cited as background
- PMID 40283579 — cited as background
- PMID 28314623 — cited as background
- PMID 34453165 — cited as background
- PMID 29622181 — cited as background
- PMID 27549563 — cited as background
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · AORT's whole pipeline · Catalyst calendar · Every registered study · What changed